- Home
- ATRC vs BKV Comparison
ATRC vs BKV Comparison
Compare ATRC & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- BKV
- Stock Information
- Founded
- ATRC 2000
- BKV 2015
- Country
- ATRC United States
- BKV United States
- Employees
- ATRC N/A
- BKV N/A
- Industry
- ATRC Medical/Dental Instruments
- BKV Oil & Gas Production
- Sector
- ATRC Health Care
- BKV Energy
- Exchange
- ATRC Nasdaq
- BKV Nasdaq
- Market Cap
- ATRC 1.6B
- BKV 1.8B
- IPO Year
- ATRC 2005
- BKV 2024
- Fundamental
- Price
- ATRC $34.13
- BKV $21.61
- Analyst Decision
- ATRC Strong Buy
- BKV Strong Buy
- Analyst Count
- ATRC 10
- BKV 9
- Target Price
- ATRC $48.50
- BKV $27.89
- AVG Volume (30 Days)
- ATRC 627.8K
- BKV 407.6K
- Earning Date
- ATRC 04-30-2025
- BKV 05-15-2025
- Dividend Yield
- ATRC N/A
- BKV N/A
- EPS Growth
- ATRC N/A
- BKV N/A
- EPS
- ATRC N/A
- BKV N/A
- Revenue
- ATRC $465,307,000.00
- BKV $615,133,000.00
- Revenue This Year
- ATRC $14.60
- BKV $36.55
- Revenue Next Year
- ATRC $12.58
- BKV $19.53
- P/E Ratio
- ATRC N/A
- BKV N/A
- Revenue Growth
- ATRC 16.55
- BKV N/A
- 52 Week Low
- ATRC $18.94
- BKV $17.39
- 52 Week High
- ATRC $43.11
- BKV $26.78
- Technical
- Relative Strength Index (RSI)
- ATRC 46.55
- BKV N/A
- Support Level
- ATRC $31.02
- BKV N/A
- Resistance Level
- ATRC $35.63
- BKV N/A
- Average True Range (ATR)
- ATRC 1.71
- BKV 0.00
- MACD
- ATRC 0.08
- BKV 0.00
- Stochastic Oscillator
- ATRC 67.46
- BKV 0.00
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
About BKV BKV Corporation Common Stock
BKV Corp is a growth-driven energy company. Its core business is to produce natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).